Apogee Therapeutics, Inc. (NASDAQ:APGE)
| Market Cap | $8.40B+239.2% |
| Revenue (ttm) | $0 |
| Net Income | -$294.37M-23.9% |
| EPS | -$4.34-4.3% |
| Shares Out | 62.20M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 0 |
| Open | $135.07 |
| Previous Close | $135.07 |
| Day's Range | $135.07 - $135.07 |
| 52-Week Range | $35.39 - $135.09 |
| Beta | 0.34 |
| Analysts | Hold |
| Price Target | $129.91(-3.82%) |
| Earnings Date | n/a |
About APGE
Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
When insiders bought and sold
1 year · open-market trades only$APGE stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in APGE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by APGE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
APGE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New APGE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to APGE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in APGE
| ARBAltShares Merger Arbitrage ETF | $2.49M |
| EVNTAltShares Event-Driven ETF | $188.30K |
| VETSPacer Military Times Best Employers ETF | $76.88K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from APGE’s recent data — informational, not investment advice
